Pharma pitches

Organizer and moderators: Ulf Simonsen, Dept. of Biomedicine, AU and Claus Olesen, Dept. of Biomedicine, AU.

09:30	First in class therapeutic candidate for seropositive rheumatoid arthritis – Mode of action studies	Tue Wenzel Kragstrup, Department of Biomedicine, AU and DTU
09:40	Muna Therapeutics	Joachim Vilstrup, Department of Biomedicine, AU
09:50	Novel treatment of female infertility	Karin Lykke Hartmann, Department of Biomedicine, AU
10:00	Gene Therapy For Cancers With Fusion-Oncogenes	Johannes Frasez Sørensen, Department of Biomedicine, AU
10:10	Small molecules for treatment of hypoxic cancer	Kristian M. Jacobsen, Department of Chemistry, AU
10:20	Bispecific nanobodies for treatment of cancer	Nick Stub Laursen, Department of Molecular Biology and Genetics, AU
10:30	Aptamers for treatment of Sars-Cov2	Jørgen Kjems, Department of Molecular Biology and Genetics, iNANO, AU
10:40	A broadly applicable prodrug platform for biopharmaceuticals	Seandean Harwood, Department of Molecular Biology and Genetics, AU
10:50	Transglutaminase 2 modulation to treat chronic kidney disease	Estéfano Pinilla, Department of Biomedicine, AU

Revised 06.03.2023